Biocure Technology Inc.

CNSX:CURE.X Stock Report

Market Cap: CA$626.7k

Biocure Technology Management

Management criteria checks 2/4

Biocure Technology's CEO is Simon Cheng, appointed in Sep 2023, has a tenure of 1.17 years. directly owns 0.056% of the company’s shares, worth CA$350.00. The average tenure of the management team and the board of directors is 4.8 years and 6.8 years respectively.

Key information

Simon Cheng

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.2yrs
CEO ownership0.06%
Management average tenure4.8yrs
Board average tenure6.8yrs

Recent management updates

Recent updates


CEO

Simon Cheng (43 yo)

1.2yrs

Tenure

Mr. Yee Sing Cheng, also known as Simon, serves as CEO & Director at Biocure Technology Inc. since September 2023. He is Director of ALDD Ventures Corp. from February 2023. He serves as CEO and Director at...


Leadership Team

NamePositionTenureCompensationOwnership
Björn Cochlovius
President3.3yrsCA$5.91kno data
Konstantin Lichtenwald
CFO, Corporate Secretary & Director6.7yrsCA$60.00k2.84%
CA$ 17.8k
Yee Cheng
CEO & Director1.2yrsno data0.056%
CA$ 350.0
Marco Nonni
Consultant6.2yrsCA$16.50kno data

4.8yrs

Average Tenure

Experienced Management: CURE.X's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Konstantin Lichtenwald
CFO, Corporate Secretary & Director6.7yrsCA$60.00k2.84%
CA$ 17.8k
Yee Cheng
CEO & Director1.2yrsno data0.056%
CA$ 350.0
Sang Kim
Independent Director9.3yrsCA$60.00k3.76%
CA$ 23.6k
Jae Shin
Member of Advisory Board6.8yrsno datano data
Hyun Lee
Member of Advisory Board6.8yrsno datano data
Heon Lee
Member of Advisory Board6.8yrsno datano data

6.8yrs

Average Tenure

43yo

Average Age

Experienced Board: CURE.X's board of directors are considered experienced (6.8 years average tenure).